已发表论文

战场针灸用于疼痛管理的实际应用及安全性:系统文献综述

 

Authors Dai N , Liu X, Wan H 

Received 16 January 2025

Accepted for publication 6 May 2025

Published 17 May 2025 Volume 2025:18 Pages 2749—2769

DOI https://doi.org/10.2147/JMDH.S517946

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Dr David C. Mohr

Nan Dai,1 Xiaohui Liu,1,2 Hejia Wan1 

1School of Nursing (Nursing School of Smart Healthcare Industry), Henan University of Chinese Medicine, Zhengzhou, People’s Republic of China; 2Henan Provincial Hospital of Traditional Chinese Medicine (The Second Affiliated Hospital of Henan University of Traditional Chinese Medicine), Zhengzhou, People’s Republic of China

Correspondence: Xiaohui Liu, Email 1173652033@qq.com

Background: Pain is complex and subjective, causing physical and psychological damage. Western medical treatments are prone to dependence, gastrointestinal problems, and organ damage. Battlefield acupuncture (BFA) integrates traditional Chinese medicine with contemporary military medicine, achieving a rapid analgesic effect. In the domain of pain management, it is effective. Despite controversy, it is recommended as an analgesic for pain populations.
Purpose: The present study evaluated the clinical efficacy and safety of BFA, with a view to informing pain management strategies and validating its credibility.
Methods: Databases including PubMed, Cochrane Library, Web of Science, and Embase were searched from 2015– 2025. Randomized controlled studies(RCTs) on BFA for pain were included. Outcome measurements were pain scores and adverse event rates. Two authors independently assessed studies using the Cochrane risk of bias tool for randomized trials(RoB-1). Heterogeneity was addressed via narrative synthesis.
Results: Of 800 articles screened, 11 RCTs (n=1,232; BFA: 530 patients) matched criteria. BFA was compared with opioids, non-opioids, exercise or physical therapies for various types of pain. Four studies reported lower BFA pain scores, and four found no difference. No severe adverse event rates were noted, but mild reactions were recorded. RoB grades: two A, eight B, one C.
Conclusion: Evidence supports the efficacy and safety of BFA for acute pain. The utilisation of BFA in the context of alleviating mild to moderate pain is recommended, particularly in conjunction with electroacupuncture therapies.However, limitations include small sample sizes, blinding issues, and inconsistent protocols. Research into specific pain types and long-term efficacy should be focused on.
Registration: PROSPERO CRD420251011281.

Keywords: pain management, acupuncture therapy, analgesics